Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

NCT06723236

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +21 more
Locations
  • UCSF - Helen Diller Family Cancer Center San Francisco, California, United States
  • Mass General Brigham Boston, Massachusetts, United States
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

NCT06959706

Conditions
Advanced Solid Tumors, Carcinoma, Neoplasms, +2 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

NCT06799637

Conditions
Adnexal Diseases, Advanced Solid Tumors, Cervical Cancers, +24 more
Locations
  • Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 24 locations
View Trial Details
Recruiting

Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002

NCT06832982

Conditions
Advanced Solid Tumors
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer hospital Fujian, Fuzhou, China
  • The First Affiliated Hospital of Zhejiang Medical University Zhejiang, Hangzhou, China
  • Harbin Medical University Cancer Hospital Heilongjiang, Harbin, China
View Trial Details
Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

NCT07262619

Conditions
Advanced Solid Tumors, Endometrial Cancer, Endometrial Neoplasms, +21 more
Locations
  • Morristown Medical Center Morristown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • GenesisCare North Shore (Oncology) Saint Leonards, New South Wales, Australia
View Trial Details

Related conditions